Correlation Between Vertex Pharmaceuticals and Molecular Pharmacology

Can any of the company-specific risk be diversified away by investing in both Vertex Pharmaceuticals and Molecular Pharmacology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vertex Pharmaceuticals and Molecular Pharmacology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Vertex Pharmaceuticals and Molecular Pharmacology, you can compare the effects of market volatilities on Vertex Pharmaceuticals and Molecular Pharmacology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vertex Pharmaceuticals with a short position of Molecular Pharmacology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vertex Pharmaceuticals and Molecular Pharmacology.

Diversification Opportunities for Vertex Pharmaceuticals and Molecular Pharmacology

0.0

Correlation Coefficient

Vertex Pharmaceuticals  Molecular Pharmacology

Pay attention - limited upside

The 3 months correlation between Vertex and Molecular is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Vertex Pharmaceuticals and Molecular Pharmacology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Molecular Pharmacology and Vertex Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vertex Pharmaceuticals are associated (or correlated) with Molecular Pharmacology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Molecular Pharmacology has no effect on the direction of Vertex Pharmaceuticals i.e., Vertex Pharmaceuticals and Molecular Pharmacology go up and down completely randomly.

Pair Corralation between Vertex Pharmaceuticals and Molecular Pharmacology

If you would invest  40,527  in Vertex Pharmaceuticals on December 21, 2024 and sell it today you would earn a total of  10,491  from holding Vertex Pharmaceuticals or generate 25.89% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	98.33%
Values	Daily Returns

Vertex Pharmaceuticals  vs.  Molecular Pharmacology

Vertex Pharmaceuticals

Risk-Adjusted Performance

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Vertex Pharmaceuticals are ranked lower than 21 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Vertex Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.

Molecular Pharmacology

Risk-Adjusted Performance

Very Weak

Over the last 90 days Molecular Pharmacology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Molecular Pharmacology is not utilizing all of its potentials. The newest stock price confusion, may contribute to short-horizon losses for the traders.

Pair Trading with Vertex Pharmaceuticals and Molecular Pharmacology

The main advantage of trading using opposite Vertex Pharmaceuticals and Molecular Pharmacology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vertex Pharmaceuticals position performs unexpectedly, Molecular Pharmacology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Molecular Pharmacology will offset losses from the drop in Molecular Pharmacology's long position.

The idea behind Vertex Pharmaceuticals and Molecular Pharmacology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.